• Version
• Download 1071
• File Size 1.24 MB
• File Count 1
• Create Date July 15, 2020
• Last Updated August 21, 2024

Position Statement: COVID-19 & Thalassaemia

Many patients with haemoglobinopathies, including thalassaemia and sickle cell disease, are at increased risk of developing severe complications from the coronavirus disease 2019 (COVID‐19). In this Position Statement, TIF reflects on general considerations and levels of risk for patients, the adaptation of haemoglobinopathy care, the blood transfusions safety and the blood supply challenges.

Attached Files